Evolus Stock

Evolus ROE

The Return on Equity (ROE) of Evolus (EOLS) as of Aug 15, 2026 is 223.50 %. In the previous year, Return on Equity (ROE) was -913.07 % — a change of -124.48% (higher).

ROE

223.50 %

YoY

-124.48%

Last updated:

In 2026, Evolus's return on equity (ROE) was 223.50 %, a -124.48% increase from the -913.07 % ROE in the previous year.

Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

ROE Details

Decoding Evolus's Return on Equity (ROE)

Evolus's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Evolus's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Evolus's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Evolus’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Evolus stock

Return on Equity (ROE) of Evolus is 223.50 % in 2026.

Return on Equity (ROE) of Evolus changed from -913.07 % to 223.50 %, representing a -124.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Evolus since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Evolus with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Evolus

All Key Metrics — Evolus